| Autor: |
Thompson GR 3rd; Division of Infectious Diseases, Department of Internal Medicine, and Department of Medical Microbiology and Immunology, University of California Davis Medical Center, Sacramento, CA, USA., Soriano A; Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, CIBER of Infectious Diseases (CIBERINFEC), Barcelona, Spain., Cornely OA; Institute for Translational Research, CECAD Cluster of Excellence, University of Cologne, and Department I of Internal Medicine, ECMM Excellence Center of Medical Mycology, University Hospital Cologne, and German Center for Infection Research (DZIF), Bonn-Cologne partner site, Cologne, Germany., Aram JA; Medical Affairs, Melinta Therapeutics, LLC, Parsippany, NJ, USA., Pappas PG; Division of Infectious Diseases, Department of Internal Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. |
